These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 33074649)

  • 1. Self-Assembly as a Molecular Strategy to Improve Immunotherapy.
    Froimchuk E; Carey ST; Edwards C; Jewell CM
    Acc Chem Res; 2020 Nov; 53(11):2534-2545. PubMed ID: 33074649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyelectrolyte Multilayers Assembled Entirely from Immune Signals on Gold Nanoparticle Templates Promote Antigen-Specific T Cell Response.
    Zhang P; Chiu YC; Tostanoski LH; Jewell CM
    ACS Nano; 2015 Jun; 9(6):6465-77. PubMed ID: 26035231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active immunotherapy for C5a-mediated inflammation using adjuvant-free self-assembled peptide nanofibers.
    Hainline KM; Haddad HF; Gilpin A; Curvino EJ; Varghese S; Collier JH
    Acta Biomater; 2024 Apr; 179():83-94. PubMed ID: 38447809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in immunotherapy delivery from implantable and injectable biomaterials.
    Leach DG; Young S; Hartgerink JD
    Acta Biomater; 2019 Apr; 88():15-31. PubMed ID: 30771535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide Hydrogels as Immunomaterials and Their Use in Cancer Immunotherapy Delivery.
    Falcone N; Ermis M; Tamay DG; Mecwan M; Monirizad M; Mathes TG; Jucaud V; Choroomi A; de Barros NR; Zhu Y; Vrana NE; Kraatz HB; Kim HJ; Khademhosseini A
    Adv Healthc Mater; 2023 Oct; 12(27):e2301096. PubMed ID: 37256647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-Immune-Engineering Approaches to Advance Cancer Immunotherapy: Lessons from Ultra-pH-Sensitive Nanoparticles.
    Li S; Bennett ZT; Sumer BD; Gao J
    Acc Chem Res; 2020 Nov; 53(11):2546-2557. PubMed ID: 33063517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein and Peptide Biomaterials for Engineered Subunit Vaccines and Immunotherapeutic Applications.
    Tsoras AN; Champion JA
    Annu Rev Chem Biomol Eng; 2019 Jun; 10():337-359. PubMed ID: 31173518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A self-adjuvanting supramolecular vaccine carrying a folded protein antigen.
    Hudalla GA; Modica JA; Tian YF; Rudra JS; Chong AS; Sun T; Mrksich M; Collier JH
    Adv Healthc Mater; 2013 Aug; 2(8):1114-9. PubMed ID: 23436779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altering Antigen Charge to Control Self-Assembly and Processing of Immune Signals During Cancer Vaccination.
    Tsai SJ; Amerman A; Jewell CM
    Front Immunol; 2020; 11():613830. PubMed ID: 33488621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotin Functionalized Self-Assembled Peptide Nanofiber as an Adjuvant for Immunomodulatory Response.
    Demircan MB; Tohumeken S; Gunduz N; Khalily MA; Tekinay T; Guler MO; Tekinay AB
    Biotechnol J; 2020 Dec; 15(12):e2000100. PubMed ID: 32679620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-Assembled Materials Made from Functional Recombinant Proteins.
    Jang Y; Champion JA
    Acc Chem Res; 2016 Oct; 49(10):2188-2198. PubMed ID: 27677734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanical Immunoengineering of T cells for Therapeutic Applications.
    Lei K; Kurum A; Tang L
    Acc Chem Res; 2020 Dec; 53(12):2777-2790. PubMed ID: 33258577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational Design of Antigen Incorporation Into Subunit Vaccine Biomaterials Can Enhance Antigen-Specific Immune Responses.
    Tsoras AN; Wong KM; Paravastu AK; Champion JA
    Front Immunol; 2020; 11():1547. PubMed ID: 32849524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancing immunotherapy using biomaterials to control tissue, cellular, and molecular level immune signaling in skin.
    Shah SA; Oakes RS; Jewell CM
    Adv Drug Deliv Rev; 2024 Jun; 209():115315. PubMed ID: 38670230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of charged peptides that self-assemble into robust nanofibers as immune-functional scaffolds.
    Zhang H; Park J; Jiang Y; Woodrow KA
    Acta Biomater; 2017 Jun; 55():183-193. PubMed ID: 28365480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cartilage penetrating cationic peptide carriers for applications in drug delivery to avascular negatively charged tissues.
    Vedadghavami A; Wagner EK; Mehta S; He T; Zhang C; Bajpayee AG
    Acta Biomater; 2019 Jul; 93():258-269. PubMed ID: 30529083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing Biomaterials to Study and Direct Antigen-Specific Immunotherapy.
    Edwards C; Carey ST; Jewell CM
    ACS Appl Bio Mater; 2023 Jun; 6(6):2017-2028. PubMed ID: 37068126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering self-assembled materials to study and direct immune function.
    Tostanoski LH; Jewell CM
    Adv Drug Deliv Rev; 2017 May; 114():60-78. PubMed ID: 28392305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered Nanoparticles for Cancer Vaccination and Immunotherapy.
    Aikins ME; Xu C; Moon JJ
    Acc Chem Res; 2020 Oct; 53(10):2094-2105. PubMed ID: 33017150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.